Benjamin Reardon and Emmanuel J Favaloro/LinkedIn
Mar 16, 2026, 15:56
Emmanuel J. Favaloro: Latest Publication from Sydney Centres on Heparin Therapy and Monitoring
Emmanuel J. Favaloro, Lead Scientist at Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
“Latest publication from the Sydney Centres for Thrombosis and Haemostasis.
Heparin Anticoagulant Therapy and Its Monitoring.
Another review ably led by Benjamin Reardon.
Enjoy! ”
Title: Heparin Anticoagulant Therapy and Its Monitoring
Authors: Benjamin Reardon, Leonardo Pasalic, Giuseppe Lippi, Emmanuel J. Favaloro
Read the Full Article on Biomolecules.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 09:05World Stroke Academy: Can Adjunct IAT Improve Tissue Reperfusion?
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?